A global assessment of the male predominance in esophageal adenocarcinoma

Oncotarget

Volumn 7, Issue 25, 2016, Pages 38876-38883

  Xie, Shao Hua ^a   Lagergren, Jesper ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Esophageal adenocarcinoma; Incidence; Male predominance; Sex difference

Indexed keywords

AFRICA; AMERICAN INDIAN; ARTICLE; ASIA; ASIAN; BLACK PERSON; CANCER INCIDENCE; CANCER PREVENTION; CARIBBEAN; CAUCASIAN; DEVELOPED COUNTRY; EARLY DIAGNOSIS; ESOPHAGEAL ADENOCARCINOMA; EUROPE; FEMALE; GENDER BIAS; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; PACIFIC ISLANDS; POPULATION DISTRIBUTION; SEX DIFFERENCE; SEX RATIO; SOUTH AND CENTRAL AMERICA; WESTERN HEMISPHERE; ADENOCARCINOMA; ESOPHAGUS TUMOR; GEOGRAPHY; GLOBAL HEALTH; INCIDENCE; PROGNOSIS;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; EUROPE; FEMALE; GEOGRAPHY; GLOBAL HEALTH; HUMANS; INCIDENCE; MALE; PROGNOSIS; SEX RATIO;

EID: 84978091772     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9113     Document Type: Article

References (33)

1. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014; 371:2499-2509.
2. Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013; 63:232-248.
3. Edgren G, Adami HO, Weiderpass E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013; 62:1406-1414.
4. Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012 Gut. 2015; 64:381-387.
5. Xie SH, Lagergren J. The male predominance in esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2016; 14: 338-347.e1. doi: 10.1016/j.cgh.2015.10.005.
6. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009; 18:1174-1182.
7. Freedman ND, Derakhshan MH, Abnet CC, Schatzkin A, Hollenbeck AR, McColl KE. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010; 46:2473-2478.
8. Cook MB, Wood SN, Cash BD, Young P, Acosta RD, Falk RT, Pfeiffer RM, Hu N, Su H, Wang L, Wang C, Gherman B, Giffen C, et al. Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a casecontrol analysis. Clin Gastroenterol Hepatol. 2015; 13:673-682.
9. Arnold M, Colquhoun A, Cook MB, Ferlay J, Forman D, Soerjomataram I. Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev. 2016; 25:90-97.
10. Institute for Health Metrics and Evaluation. (2014). Overweight and Obesity Viz. (Seattle, WA: IHME, University of Washington). Available at http://vizhub.healthdata.org/obesity [Accessed on 20 Feb 2016].
11. Hong Kong Tobacco Control Office, Hong Kong Department of Health. Pattern of smoking in Hong Kong. Available at http://www.tco.gov.hk/english/infostation/infostation_sta_01.html [Accessed on 20 Feb 2016].
12. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012; 41:1706-1718.
13. Rutegard M, Nordenstedt H, Lu Y, Lagergren J, Lagergren P. Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma. Br J Cancer. 2010; 103:735-740.
14. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014; 63:871-880.
15. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013; 11:1399-1412 e1397.
16. Lagergren K, Mattsson F, Lagergren J. Abdominal fat and male excess of esophageal adenocarcinoma. Epidemiology. 2013; 24:465-466.
17. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005; 162:1050-1061.
18. Erichsen R, Robertson D, Farkas DK, Pedersen L, Pohl H, Baron JA, Sorensen HT. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux. Clin Gastroenterol Hepatol. 2012; 10:475-480 e471.
19. Okimoto E, Ishimura N, Morito Y, Mikami H, Shimura S, Uno G, Tamagawa Y, Aimi M, Oshima N, Kawashima K, Kazumori H, Sato S, Ishihara S, et al. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community. J Gastroenterol Hepatol. 2015; 30:1140-1146.
20. Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005; 40:1005-1009.
21. Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D, McColl KE. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut. 2009; 58:16-23.
22. United Nations, Department of Economic and Social Affairs, Population Division. (2015). World Contraceptive Use 2015. (New York: United Nations). Available at http://www.un.org/en/development/desa/population/publications/dataset/contraception/wcu2015.shtml [Accessed on 20 Feb 2016].
23. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009; 20:556-563.
24. Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, Shekelle P, Clinical Guidelines Committee of the American College of P. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2012; 157:808-816.
25. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Cancer Incidence in Five Continents, Vol. X, IARC Scientific Publication No. 164. (Lyon: International Agency for Research on Cancer). 2014.
26. Ferlay J, Bray F, Steliarova-Foucher E, Forman D. Cancer Incidence in Five Continents, CI5plus. IARC CancerBase No. 9. (Lyon: International Agency for Research on Cancer). 2014.
27. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer Incidence in Five Continents, Vol. IX, IARC Scientific Publications No. 160. (Lyon: International Agency for Research on Cancer). 2007.
28. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Vol. VIII, IARC Scientific Publications No. 155. (Lyon: International Agency for Research on Cancer). 2002.
29. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents, Vol. VII, IARC Scientific Publications No. 143. (Lyon: International Agency for Research on Cancer). 1997.
30. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper Series: No.31. (Geneva: World Health Organization). 2001.
31. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997; 16:791-801.
32. SAS Institute Inc. SAS/STAT 12.1 User's Guide. (Cary, NC: SAS Institute Inc.).
33. United Nations, Department of Economic and Social Affairs, Population Division. (2015). World Population Prospects: The 2015 Revision. (New York: United Nations).